Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Wael Al-Zoughbi, Martin Pichler, Gregor Gorkiewicz, Barbara Guertl-Lackner, Johannes Haybaeck, Stephan W. Jahn, Carolin Lackner, Bernadette Liegl-Atzwanger, Helmut Popper, Silvia Schauer, Elisa Nusshold, Alida S. D. Kindt, Zlatko Trajanoski, Michael R. Speicher, Guenther Haemmerle, Robert Zimmermann, Rudolf Zechner, Paul W. Vesely, Gerald Hoefler
Published May 17, 2016 · Vol. 7, No. 23 · pp. 33832-33840
Huang-Ge Zhang, Pengxiao Cao, Yun Teng, Xin Hu, Qilong Wang, Ashish S. Yeri, Xiaoying Zhuang, Abhilash Samykutty, Jingyao Mu, Zhong-Bin Deng, Lifeng Zhang, James A. Mobley, Jun Yan, Kendall Van Keuren-Jensen, Donald Miller
Published May 12, 2016 · Vol. 7, No. 27 · pp. 41346-41362